Title | Identification of a pathogenic PMP2 variant in a multi-generational family with CMT type 1: Clinical gene panels versus genome-wide approaches to molecular diagnosis. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Punetha, J, Mackay-Loder, L, Harel, T, Coban-Akdemir, Z, Jhangiani, SN, Gibbs, RA, Lee, I, Terespolsky, D, Lupski, JR, Posey, JE |
Journal | Mol Genet Metab |
Volume | 125 |
Issue | 3 |
Pagination | 302-304 |
Date Published | 2018 Nov |
ISSN | 1096-7206 |
Keywords | Charcot-Marie-Tooth Disease, Demyelinating Diseases, Humans, Mutation, Myelin P2 Protein, Neural Conduction, Pathology, Molecular, Peripheral Nervous System Diseases |
Abstract | Charcot-Marie-Tooth (CMT) disease type 1 is an inherited peripheral neuropathy characterized by demyelination and reduced nerve conduction velocities. We present a multi-generational family with peripheral neuropathy in whom clinical CMT panel testing failed to conclude a molecular diagnosis. We found a PMP2 pathogenic variant c.155T > C, p.(Ile52Thr) that segregates with disease suggesting that PMP2 variants should be considered in patients with neuropathy and that it may be prudent to include in clinical CMT gene panels. |
DOI | 10.1016/j.ymgme.2018.08.005 |
Alternate Journal | Mol Genet Metab |
PubMed ID | 30249361 |
PubMed Central ID | PMC6326168 |
Grant List | K08 HG008986 / HG / NHGRI NIH HHS / United States R35 NS105078 / NS / NINDS NIH HHS / United States U54 HG006542 / HG / NHGRI NIH HHS / United States UM1 HG006542 / HG / NHGRI NIH HHS / United States |
Identification of a pathogenic PMP2 variant in a multi-generational family with CMT type 1: Clinical gene panels versus genome-wide approaches to molecular diagnosis.
Similar Publications
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants. Cancer Res Commun. 2024;4(10):2714-2723. | .
StratoMod: predicting sequencing and variant calling errors with interpretable machine learning. Commun Biol. 2024;7(1):1316. | .
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. BMC Med Genomics. 2024;17(1):255. | .